Phathom Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Phathom Pharmaceuticals Inc cash flow-to-debt ratio. Phathom Pharmaceuticals Inc (PHAT) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of $-14.12 Million could theoretically repay 0% of its total liabilities ($662.82 Million) in one year. See Phathom Pharmaceuticals Inc (PHAT) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Phathom Pharmaceuticals Inc (2018–2024)
Cash flow-to-debt ratio of Phathom Pharmaceuticals Inc from 2018 to 2024. Historical debt coverage capacity for Phathom Pharmaceuticals Inc across 7 annual periods. Also explore PHAT year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Phathom Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2018–2024)
Phathom Pharmaceuticals Inc cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for Phathom Pharmaceuticals Inc. For the full cash flow conversion analysis, see PHAT cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.42x | $-266.77 Million | $631.90 Million | ▼ -49.3% |
| 2023 | -0.28x | $-137.58 Million | $486.60 Million | ▲ +53.8% |
| 2022 | -0.61x | $-146.53 Million | $239.62 Million | ▲ +51.7% |
| 2021 | -1.27x | $-148.46 Million | $117.28 Million | ▼ -83.2% |
| 2020 | -0.69x | $-69.69 Million | $100.84 Million | ▲ +44.7% |
| 2019 | -1.25x | $-36.51 Million | $29.22 Million | ▼ -167.2% |
| 2018 | -0.47x | $-1.02 Million | $2.19 Million | — |